Based on the latest data point from August 2025, GEN is trading at $30.20 per share, positioning the stock in the **Warning** zone above the 31.1x PE multiple boundary. The current price significantly exceeds all PE ratio boundaries: 2.2x ($2.15), 8.0x ($7.76), 13.8x ($13.37), 19.6x ($18.98), 25.4x ($24.59), and 31.1x ($30.20). This indicates the stock is trading at severe overvaluation levels, with the price sitting at the upper limit of the PE river chart's highest valuation band, suggesting potential downside risk and warranting caution for new investments. Analyzing the historical trend from 2020 to 2025, GEN has experienced dramatic valuation expansion over this period. The stock began in 2020 trading in the **Fair** to **Watch** zones between 8.0x-19.6x PE multiples, with prices ranging from $13-20. A significant valuation compression occurred in early 2021 when the PE boundaries shifted dramatically lower, temporarily placing the stock in extreme overvaluation territory. However, the most notable trend has been the steady price appreciation since 2023, particularly accelerating from late 2023 onwards. The stock moved from the **Undervalued** zone (below 2.2x PE) in mid-2024 at around $2.15, through successive PE bands, ultimately reaching the **Warning** zone by 2025. This represents a more than 10-fold price increase from the 2024 lows, indicating either substantial earnings deterioration that compressed the PE boundaries or significant market speculation driving prices to unsustainable levels relative to historical valuation metrics.